Forced expiratory volume in one second as a prognostic factor in advanced non-small cell lung cancer

Journal of Thoracic Oncology

Volumn 6, Issue 2, 2011, Pages 305-309

  Lee, Jin Hwa ^a   Song, Eun Mi ^a   Sim, Yun Su ^a   Ryu, Yon Ju ^a   Chang, Jung Hyun ^a  

^a Ewha Womans University School of Medicine   (South Korea)

Author keywords

Forced expiratory volume; Mortality; Non small cell lung cancer; Spirometry; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BODY MASS; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; DISEASE COURSE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; LUNG ADENOCARCINOMA; LUNG FUNCTION; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPIROMETRY; TERTIARY HEALTH CARE;

EID: 79551542832     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318201884b     Document Type: Article

References (31)

1. Petty TL. Are COPD and lung cancer two manifestations of the same disease? Chest 2005;128:1895-1897.
2. Wilson DO, Weissfeld JL, Balkan A, et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med 2008;178:738-744.
3. Nomura A, Stemmermann GN, Chyou PH, et al. Prospective study of pulmonary function and lung cancer. Am Rev Respir Dis 1991;144:307-311.
4. Skillrud DM, Offord KP, Miller RD. Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study. Ann Intern Med 1986;105:503-507.
5. Van den Eeden SK, Friedman GD. Forced expiratory volume (1 second) and lung cancer incidence and mortality. Epidemiology 1992;3:253-257.
6. Calabrò E, Randi G, La Vecchia C, et al. Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes. Eur Respir J 2010;35:146-151.
7. Reif MS, Socinski MA, Rivera MP. Evidence-based medicine in the treatment of non-small-cell lung cancer. Clin Chest Med 2000;21:107-120.
8. Legge JS, Palmer KN. Pulmonary function in bronchial carcinoma. Thorax 1973;28:588-591.
9. Win T, Jackson A, Sharples L, et al. Relationship between pulmonary function and lung cancer surgical outcome. Eur Respir J 2005;25:594-599.
10. Birim O, Kappetein AP, van Klaveren RJ, et al. Prognostic factors in non-small cell lung cancer surgery. Eur J Surg Oncol 2006;32:12-23.
11. Brundage MD, Davies D, Mackillop WJ. Prognostic factors in non-small cell lung cancer: a decade of progress. Chest 2002;122:1037-1057.
12. Stewart LA, Pignon JP. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ 1995;311:899-909.
13. Spiro SG, Rudd RM, Souhami RL, et al. Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life. Thorax 2004;59:828-836.
14. Albain KS, Crowley JJ, LeBlanc M, et al. Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience. J Clin Oncol 1991;9:1618-1626.
15. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152:1107-1136.
16. Hole DJ, Watt GC, Davey-Smith G, et al. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996;313:711-715.
17. Schünemann HJ, Dorn J, Grant BJ, et al. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 2000;118:656-664.
18. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease [GOLD Web site], 2009. Available at: http://www.goldcopd.com/. Accessed September 3, 2010.
19. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-1012.
20. Sugiura S, Ando Y, Minami H, et al. Prognostic value of pleural effusion in patients with non-small cell lung cancer. Clin Cancer Res 1997;3:47-50.
21. Naito T, Satoh H, Ishikawa H, et al. Pleural effusion as a significant prognostic factor in non-small cell lung cancer. Anticancer Res 1997;17:4743-4746.
22. Alon BN, Anson BL. Pleural effusion in patients with non-small cell carcinoma-stage IV and not T4. Lung Cancer 2007;57:123.
23. Travis WD, Travis LB, Devesa SS. Lung cancer. Cancer 1995;75:191S-202S.
24. Padilla J, Calvo V, Peñalver JC, et al. Survival and risk model for stage IB non-small cell lung cancer. Lung Cancer 2002;36:43-48.
25. Nomura A, Heilbrun LK, Stemmermann GN. Body mass index as a predictor of cancer in men. J Natl Cancer Inst 1985;74:319-323.
26. Kabat GC, Wynder EL. Body mass index and lung cancer risk. Am J Epidemiol 1992;135:769-774.
27. Koh WP, Yuan JM, Wang R, et al. Body mass index and smokingrelated lung cancer risk in the Singapore Chinese Health Study. Br J Cancer 2010;102:610-614.
28. Yang L, Yang G, Zhou M, et al. Body mass index and mortality from lung cancer in smokers and nonsmokers: a nationally representative prospective study of 220, 000 men in China. Int J Cancer 2009;125:2136-2143.
29. Sakurai H, Asamura H, Goya T, et al. Survival differences by gender for resected non-small cell lung cancer: a retrospective analysis of 12, 509 cases in a Japanese Lung Cancer Registry Study. J Thorac Oncol 2010;5:1594-1601.
30. Chansky K, Sculier JP, Crowley JJ, et al. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer. J Thorac Oncol 2009;4:792-801.
31. Toyooka S, Takano T, Kosaka T, et al. Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib-treated patients with lung adenocarcinoma. Cancer Sci 2008;99:303-308.